Cargando…
Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients
BACKGROUND: Colorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases. AIM: To investigate risk factors for extranodal TDs in stage III colon...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107215/ https://www.ncbi.nlm.nih.gov/pubmed/37077516 http://dx.doi.org/10.3748/wjg.v29.i11.1735 |
_version_ | 1785026558780506112 |
---|---|
author | Jhuang, Yi-Han Chou, Yu-Ching Lin, Yu-Chun Hu, Je-Ming Pu, Ta-Wei Chen, Chao-Yang |
author_facet | Jhuang, Yi-Han Chou, Yu-Ching Lin, Yu-Chun Hu, Je-Ming Pu, Ta-Wei Chen, Chao-Yang |
author_sort | Jhuang, Yi-Han |
collection | PubMed |
description | BACKGROUND: Colorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases. AIM: To investigate risk factors for extranodal TDs in stage III colon cancer. METHODS: This was a retrospective cohort study. We selected 155 individuals diagnosed with stage III colon cancer from the database of the Cancer Registry of the Tri-Service General Hospital. The patients were allocated into the groups with/without N1c. Multivariate Cox regression analysis and Kaplan-Meier method were done. The primary outcomes investigate the association between the covariates and extranodal TDs, and prognostic significance of the covariates regarding the survival. RESULTS: There were 136 individuals in the non-N1c group and 19 individuals in the N1c group. Patients with lymphovascular invasion (LVI) had a higher risk of TDs. Overall survival rates of patients with and without LVI were 6.64 years and 8.61 years, respectively (P = 0.027). The N1c patients without LVI had higher overall survival than those who with LVI (7.73 years vs 4.42 years, P = 0.010). CONCLUSION: Patients having stage III colon cancer with LVI have a higher probability of having TDs than those with stage III colon cancer without LVI. Stage III colon cancer patients with TDs and LVI could have poor prognosis and outcome. |
format | Online Article Text |
id | pubmed-10107215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-101072152023-04-18 Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients Jhuang, Yi-Han Chou, Yu-Ching Lin, Yu-Chun Hu, Je-Ming Pu, Ta-Wei Chen, Chao-Yang World J Gastroenterol Retrospective Cohort Study BACKGROUND: Colorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases. AIM: To investigate risk factors for extranodal TDs in stage III colon cancer. METHODS: This was a retrospective cohort study. We selected 155 individuals diagnosed with stage III colon cancer from the database of the Cancer Registry of the Tri-Service General Hospital. The patients were allocated into the groups with/without N1c. Multivariate Cox regression analysis and Kaplan-Meier method were done. The primary outcomes investigate the association between the covariates and extranodal TDs, and prognostic significance of the covariates regarding the survival. RESULTS: There were 136 individuals in the non-N1c group and 19 individuals in the N1c group. Patients with lymphovascular invasion (LVI) had a higher risk of TDs. Overall survival rates of patients with and without LVI were 6.64 years and 8.61 years, respectively (P = 0.027). The N1c patients without LVI had higher overall survival than those who with LVI (7.73 years vs 4.42 years, P = 0.010). CONCLUSION: Patients having stage III colon cancer with LVI have a higher probability of having TDs than those with stage III colon cancer without LVI. Stage III colon cancer patients with TDs and LVI could have poor prognosis and outcome. Baishideng Publishing Group Inc 2023-03-21 2023-03-21 /pmc/articles/PMC10107215/ /pubmed/37077516 http://dx.doi.org/10.3748/wjg.v29.i11.1735 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Cohort Study Jhuang, Yi-Han Chou, Yu-Ching Lin, Yu-Chun Hu, Je-Ming Pu, Ta-Wei Chen, Chao-Yang Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients |
title | Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients |
title_full | Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients |
title_fullStr | Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients |
title_full_unstemmed | Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients |
title_short | Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients |
title_sort | risk factors predict microscopic extranodal tumor deposits in advanced stage iii colon cancer patients |
topic | Retrospective Cohort Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107215/ https://www.ncbi.nlm.nih.gov/pubmed/37077516 http://dx.doi.org/10.3748/wjg.v29.i11.1735 |
work_keys_str_mv | AT jhuangyihan riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients AT chouyuching riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients AT linyuchun riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients AT hujeming riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients AT putawei riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients AT chenchaoyang riskfactorspredictmicroscopicextranodaltumordepositsinadvancedstageiiicoloncancerpatients |